Patrick Baeuerle
2022
In 2022, Patrick Baeuerle earned a total compensation of $2M as Chief Scientific Officer at Cullinan Therapeutics, a 58% decrease compared to previous year.
Compensation breakdown
| Bonus | $266,234 |
|---|---|
| Option Awards | $686,250 |
| Salary | $463,500 |
| Stock Awards | $510,000 |
| Other | $34,000 |
| Total | $1,959,984 |
Baeuerle received $686.3K in option awards, accounting for 35% of the total pay in 2022.
Baeuerle also received $266.2K in bonus, $463.5K in salary, $510K in stock awards and $34K in other compensation.
Rankings
In 2022, Patrick Baeuerle's compensation ranked 1,784th out of 5,760 executives tracked by ExecPay. In other words, Baeuerle earned more than 69.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,784 out of 5,760 | 69th |
Division Manufacturing | 939 out of 3,136 | 70th |
Major group Chemicals And Allied Products | 380 out of 1,422 | 73rd |
Industry group Drugs | 348 out of 1,323 | 74th |
Industry Biological Products, Except Diagnostic Substances | 86 out of 291 | 70th |
Source: SEC filing on April 21, 2023.
Baeuerle's colleagues
We found two more compensation records of executives who worked with Patrick Baeuerle at Cullinan Therapeutics in 2022.